|
Actonel provides vertebral fracture risk reduction in women with postmenopausal osteoporosis at risk for upper GI side effects.
Publication: Asia Africa Intelligence Wire Publication Date: 18-OCT-04 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2004 Financial Times Ltd.
(From Chemical Business NewsBase - Press Release)
Actonel (risedronate sodium tablets) reduces the risk of vertebral fracture up to 62% at one year in women with postmenopausal osteoporosis who are at risk for upper gastrointestinal (GI) side effects, according to new analyses presented at the American College of Rheumatology (ACR) annual meeting. Actonel is the only osteoporosis therapy proven...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Asia Africa Intelligence Wire |
Ciba brings special effects.
October 11, 2004
|
India's plastics sector primed for growth.
October 11, 2004
|
Western Europe plastics demand up 1.9% in 2003.
October 11, 2004
|
Sluggish outlook for flexible packaging in Europe.
October 11, 2004
|
Asahi Kasei Chemicals goes to Russia.
October 11, 2004
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
